AstraZeneca

Phone: +144 (0)20 3749 5000

E-mail: Medical.InformationUK@astrazeneca.com

Web: https://www.astrazeneca.com

Type	Public limited company
Traded as	LSE: AZN FTSE 100 component Nasdaq Stockholm: AZN OMX Stockholm 30 component Nasdaq: AZN Nasdaq-100 component
ISIN
Industry	Pharmaceutical Biotechnology
Predecessors	Astra AB Zeneca Group plc
Founded	6 April 1999 (1999-04-06)
Headquarters	1 Francis Crick Avenue, Cambridge, UK
Area served	Global
Key people	Leif Johansson (Chairman) Pascal Soriot (CEO)
Products	Pharmaceutical products
Revenue	US$37.417 billion (2021)
Operating income	US$1.056 billion (2021)
Net income	US$0.115 billion (2021)
Total assets	US$105.363 billion (2021)
Total equity	US$39.287 billion (2021)
Number of employees	76,100 (2020)
Subsidiaries	Alexion Pharmaceuticals MedImmune
Website	www.astrazeneca.com

We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide. Our purpose and values help explain why we exist, what we hope to accomplish, the behaviours we value, how we will achieve our goals, and the promise of our brand to our stakeholders.

For detailed contact information visit location pages below.